Microbot Medical
MBOT
29 hedge funds and large institutions have $3.9M invested in Microbot Medical in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 7 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 2
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
4% more funds holding
Funds holding: 28 → 29 (+1)
2.41% less ownership
Funds ownership: 12.19% → 9.78% (-2.4%)
40% less capital invested
Capital invested by funds: $6.54M → $3.9M (-$2.65M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.59M |
| 2 |
BlackRock
New York
|
+$258K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$162K |
| 4 |
Morgan Stanley
New York
|
+$126K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$112K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$773K |
| 2 |
Renaissance Technologies
New York
|
-$647K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$135K |
| 4 |
Bank of New York Mellon
New York
|
-$58.1K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$41 |
MBOT Hedge Fund Activity: Q1 2020 in Review
29 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2020, worth a combined $3.9M — down 40% from $6.54M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new MBOT positions and 7 closed out — a net gain of 4 holders — while 10 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.59M. The largest seller was Sabby Management, exiting entirely with an estimated $773K sold.
- 29 institutional investors held Microbot Medical (MBOT) as of Q1 2020, up from 28 in Q4 2019.
- Funds reported $3.9M of Microbot Medical stock for Q1 2020, down 40% quarter-over-quarter.
- 11 funds opened new Microbot Medical positions in Q1 2020 and 7 closed out, a net change of +4 holders.
- The largest Microbot Medical buyer in Q1 2020 was Vanguard Group, an estimated $1.59M added.
- The largest Microbot Medical seller in Q1 2020 was Sabby Management, an estimated $773K sold.
Based on aggregated 13F filings for Q1 2020.